Fibromyalgia  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Published by Delve Insight: 31 May 2017 | 86108

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Fibromyalgia 
or contact our sales team for personal assistance: phone +44 (0) 1305 753769 or email office@sectorpublishing.com.

Introduction

DelveInsight “Fibromyalgia  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Fibromyalgia  in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Fibromyalgia  prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Fibromyalgia . The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report

• The Report includes the prevalent population and how will it change over the next eight years.

• Prevalent or incident cases segmented by age and sex.

• Coverage of key Fibromyalgia  subpopulations and its prevalent or incident cases

• The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Fibromyalgia  market.

• Identifying prevalent patient populations as well as risk factors in the global Fibromyalgia  market will help to improve product design, pricing, and launch plans.

• Organize sales and marketing efforts by identifying the best opportunities for Fibromyalgia  therapeutics in each of the markets covered.

Table of Contents
for Fibromyalgia  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

List Of Tables
in Fibromyalgia  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Table 1: Clinical subtypes of Indication

Table 2: Risk Factors

Table 3: Prevalence cases (%) Region wise

Table 4: Sources used for forecasting the data

Table 5: Fibromyalgia  Global Epidemiology, (2013-2023)

Table 6: Prevalent Cases of Fibromyalgia  (Ages =XX Years), US (2013-2023)

Table 7: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), US (2013-2023)

Table 8: Prevalent Cases By Fibromyalgia  Sub-population, US (2013-2023)

Table 9: Prevalent Cases of Fibromyalgia  (Ages =XX Years), United Kingdom (2013-2023)

Table 10: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), United Kingdom (2013-2023)

Table 11: Prevalent Cases By Fibromyalgia  Sub-population, United Kingdom (2013-2023)

Table 12: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Germany (2013-2023)

Table 13: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Germany (2013-2023)

Table 14: Prevalent Cases By Fibromyalgia  Sub-population, Germany (2013-2023)

Table 15: Prevalent Cases of Fibromyalgia  (Ages =XX Years), France (2013-2023)

Table 16: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), France (2013-2023)

Table 17: Prevalent Cases By Fibromyalgia  Sub-population, France (2013-2023)

Table 18: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Italy (2013-2023)

Table 19: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Italy (2013-2023)

Table 20: Prevalent Cases By Fibromyalgia  Sub-population, Italy (2013-2023)

Table 21: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Spain (2013-2023)

Table 22: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Spain (2013-2023)

Table 23: Prevalent Cases By Fibromyalgia  Sub-population, Spain (2013-2023)

Table 24: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Japan (2013-2023)

Table 25: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Japan (2013-2023)

Table 26: Prevalent Cases By Fibromyalgia  Sub-population, Japan (2013-2023)

List Of Figures, Charts and Diagrams
in Fibromyalgia  - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Figure 1: Prevalence cases (%) Region wise

Figure 2: Sources used for forecasting the data

Figure 3: Fibromyalgia  Global Epidemiology, (2013-2023)

Figure 4: Prevalent Cases of Fibromyalgia  (Ages =XX Years), US (2013-2023)

Figure 5: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), US (2013-2023)

Figure 6: Prevalent Cases By Fibromyalgia  Sub-population,US (2013-2023)

Figure 7: Prevalent Cases of Fibromyalgia  (Ages =XX Years), United Kingdom (2013-2023)

Figure 8: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), United Kingdom (2013-2023)

Figure 9: Prevalent Cases By Fibromyalgia  Sub-population,United Kingdom (2013-2023)

Figure 10: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Germany (2013-2023)

Figure 11: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Germany (2013-2023)

Figure 12: Prevalent Cases By Fibromyalgia  Sub-population,Germany (2013-2023)

Figure 13: Prevalent Cases of Fibromyalgia  (Ages =XX Years), France (2013-2023)

Figure 14: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), France (2013-2023)

Figure 15: Prevalent Cases By Fibromyalgia  Sub-population,France (2013-2023)

Figure 16: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Italy (2013-2023)

Figure 17: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Italy (2013-2023)

Figure 18: Prevalent Cases By Fibromyalgia  Sub-population,Italy (2013-2023)

Figure 19: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Spain (2013-2023)

Figure 20: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Spain (2013-2023)

Figure 21: Prevalent Cases By Fibromyalgia  Sub-population,Spain (2013-2023)

Figure 22: Prevalent Cases of Fibromyalgia  (Ages =XX Years), Japan (2013-2023)

Figure 23: Prevalent Cases of Fibromyalgia  By Sex (Males & Females), Japan (2013-2023)

Figure 24: Prevalent Cases By Fibromyalgia  Sub-population,Japan (2013-2023)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

86108 | DIEPR2017121

Number of Pages

40

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Fibromyalgia - Pipeline Review, H1 2017
Fibromyalgia - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Heal...
28 Feb 2017 by Global Markets Direct USD $2,000 More Info
Fibromyalgia Global Clinical Trials Review, H2, 2016
Fibromyalgia Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Fibr...
30 Sep 2016 by Global Data USD $2,500 More Info
Fibromyalgia - US Drug Forecast and Market Analysis to 2023
Fibromyalgia - US Drug Forecast and Market Analysis to 2023SummaryThe fibromyalgia market is relativ...
01 May 2015 by Global Data USD $4,995 More Info
Fibromyalgia - 5EU Drug Forecast and Market Analysis to 2023
Fibromyalgia - 5EU Drug Forecast and Market Analysis to 2023SummaryThe fibromyalgia market is relati...
01 May 2015 by Global Data USD $6,995 More Info
Fibromyalgia - Japan Drug Forecast and Market Analysis to 2023
Fibromyalgia - Japan Drug Forecast and Market Analysis to 2023SummaryThe fibromyalgia market is rela...
01 May 2015 by Global Data USD $4,995 More Info
Fibromyalgia - Current and Future Players
Fibromyalgia - Current and Future PlayersSummaryGlobalData has released its pharma report, “Fibromya...
01 May 2015 by Global Data USD $2,995 More Info
Fibromyalgia - US Drug Forecast and Market Analysis to 2023
Fibromyalgia - US Drug Forecast and Market Analysis to 2023SummaryThe fibromyalgia market is relativ...
01 May 2015 by Global Data USD $4,995 More Info
Fibromyalgia - 5EU Drug Forecast and Market Analysis to 2023
Fibromyalgia - 5EU Drug Forecast and Market Analysis to 2023SummaryThe fibromyalgia market is relati...
01 May 2015 by Global Data USD $6,995 More Info
Fibromyalgia - Japan Drug Forecast and Market Analysis to 2023
Fibromyalgia - Japan Drug Forecast and Market Analysis to 2023SummaryThe fibromyalgia market is rela...
01 May 2015 by Global Data USD $4,995 More Info
Fibromyalgia - Current and Future Players
Fibromyalgia - Current and Future PlayersSummaryGlobalData has released its pharma report, “Fibromya...
01 May 2015 by Global Data USD $2,995 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data